Tag-72-reactive antibody CC49 recognizes molecules expressed by hematopoietic cell linesNICOLET, C. M; SIEGEL, D. H; SURFUS, J. E et al.Tumor biology. 1997, Vol 18, Num 6, pp 356-366, issn 1010-4283Article

Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3THOR, A; OHUCHI, N; SZPAK, C. A et al.Cancer research (Baltimore). 1986, Vol 46, Num 6, pp 3118-3124, issn 0008-5472Article

Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3JACOBS, I. J; ORAM, D. H; BAST, R. C et al.Obstetrics and gynecology (New York. 1953). 1992, Vol 80, Num 3, pp 396-399, issn 0029-7844, 1Article

CA 125 assay used in conjunction with CA 15-3 and TAG-72 assays for discrimination between malignant and non-malignant diseases of the ovaryEINHORN, N; KNAPP, R. C; BAST, R. C et al.Acta oncologica (Stockholm). 1989, Vol 28, Num 5, pp 655-657, issn 0284-186X, 3 p.Article

Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissueTAKASAKI, H; TEMPERO, M. A; UCHIDA, E et al.International journal of cancer. 1988, Vol 42, Num 5, pp 681-686, issn 0020-7136Article

Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3JOHNSON, V. G; SCHLOM, J; PATERSON, A. J et al.Cancer research (Baltimore). 1986, Vol 46, Num 2, pp 850-857, issn 0008-5472Article

Differential TAG-72 epitope expression in breast cancer and lymph node metastases: A marker of a more aggressive phenotypeGALIETTA, Annamaria; PIZZI, Claudia; MARIANI-COSTANTINI, Renato et al.Oncology reports. 2002, Vol 9, Num 1, pp 135-140, issn 1021-335XArticle

Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugatesSCHLOM, J; EGGENSPERGER, D; COLCHER, D et al.Cancer research (Baltimore). 1992, Vol 52, Num 5, pp 1067-1072, issn 0008-5472Article

Preoperative serum tumor-associated antigen levels in women with pelvic massesSOPER, J. T; HUNTER, V. J; DALY, L et al.Obstetrics and gynecology (New York. 1953). 1990, Vol 75, Num 2, pp 249-254, issn 0029-7844, 6 p.Article

Intraoperative detection of occult colon cancer micrometastases using ¹²⁵I-radiolabeled monoclonal antibody CC49COTE, R. J; HOUCHENS, D. P; HITCHCOCK, C. L et al.Cancer. 1996, Vol 77, Num 4, pp 613-620, issn 0008-543XArticle

Immunoscintigraphy of human colon cancer xenografts in nude mice using a second-generation TAG-72 monoclonal antibody labelled with ⁹⁹Tc^mREILLY, R. M; NG, K; POLIHRONIS, J et al.Nuclear medicine communications. 1994, Vol 15, Num 5, pp 379-387, issn 0143-3636Article

Interferon α enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancerMAHVI, D. M; MADSEN, J. A; WITT, P. L et al.Cancer immunology and immunotherapy. 1995, Vol 40, Num 5, pp 311-314, issn 0340-7004Article

Tissue distribution of TAG-72 in malignant mixed mullerian tumors of the uterusHACKETT, T. E; KAMINSKI, P; OLT, G. J et al.Gynecologic oncology (Print). 1994, Vol 52, Num 2, pp 165-171, issn 0090-8258Article

Monoclonal antibodies in the management of carcinoma patientsROSELLI, M; CASCIANI, C; GUADAGNI, F et al.Medical oncology and tumor pharmacotherapy. 1991, Vol 8, Num 4, pp 223-228, issn 0736-0118Article

Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72)KLUG, T. L; SATTLER, M. A; COLCHER, D et al.International journal of cancer. 1986, Vol 38, Num 5, pp 661-669, issn 0020-7136Article

Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomasKARAN, Dev; JOHANSSON, Sonny L; LIN, Ming-Fong et al.Oncology reports. 2001, Vol 8, Num 5, pp 1123-1126, issn 1021-335XArticle

TAG-72, CA 19.9 and CEA as tumor markers in gastric cancerFIRELLA, X; FUSTER, J; MOLINA, R et al.Acta oncologica (Stockholm). 1994, Vol 33, Num 7, pp 747-751, issn 0284-186XArticle

Editorial : in vivo fate of monoclonal antibody B72.3HARPERN, S. E.The Journal of nuclear medicine (1978). 1990, Vol 31, Num 7, pp 1143-1146, issn 0161-5505, 4 p.Article

Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72IRVINE, K; SCHLOM, J.Cancer immunology and immunotherapy. 1993, Vol 36, Num 5, pp 281-292, issn 0340-7004Article

Comparative pharmacokinetics of In-111 and Y-90 B72.3 in patients following single dose intravenous administrationZIMMER, A. M; KUZEL, T. M; SAMUELSON, E et al.Antibody immunoconjugates, and radiopharmaceuticals. 1992, Vol 5, Num 3, pp 285-294, issn 0892-7049Conference Paper

The intraoperative detection of ovarian adenocarcinoma using radiolabeled CC49 monoclonal antibody and a hand-held gamma-detecting probeMCINTOSH, D. G; COLCHER, D; SEEMAYER, T et al.Cancer biotherapy & radiopharmaceuticals. 1997, Vol 12, Num 4, pp 287-294, issn 1084-9785Article

Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different type of carcinomasKATARI, R. S; FERNTEN, P. D; SCHLOM, J et al.Cancer research (Baltimore). 1990, Vol 50, Num 16, pp 4885-4890, issn 0008-5472, 6 p.Article

Construction of phosphorylatable monoclonal antibody CC49 with a casein kinase II recognition siteLEI LIN; GILLIES, S. D; SCHLOM, J et al.Anticancer research. 1998, Vol 18, Num 6A, pp 3971-3978, issn 0250-7005Conference Paper

Construction and purification of domain-deleted immunoglobulin variants of the recombinant/chimeric B72.3 (y1) monoclonal antibodyCALVO, B; KASHMIRI, S. V. S; HUTZELL, P et al.Cancer biotherapy. 1993, Vol 8, Num 1, pp 95-109, issn 1062-8401Article

Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patientsGALLINGER, S; REILLY, R. M; KIRSH, J. C et al.Cancer research (Baltimore). 1993, Vol 53, Num 2, pp 271-278, issn 0008-5472Article